Page last updated: 2024-08-23

1-deoxynojirimycin and Cherry Red Spot Myoclonus Syndrome

1-deoxynojirimycin has been researched along with Cherry Red Spot Myoclonus Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boudewyn, LC; Dobrenis, K; Grishchuk, Y; Kuchar, L; Ledvinova, J; Sikora, J; Walkley, SU; Wang, SL	1
Baris, H; Cohen, IJ; Mistry, PK; Sands, MS	1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Cherry Red Spot Myoclonus Syndrome

Article	Year
N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV. Neurobiology of disease, 2017, Volume: 105 Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Cell Count; Cerebellum; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Gliosis; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mucolipidoses; Nerve Tissue Proteins; Psychomotor Performance; Purkinje Cells; Retina; Transient Receptor Potential Channels	2017
Overcoming the Next Barriers to Successful Therapy. Pediatric endocrinology reviews : PER, 2016, Volume: 13 Suppl 1 Topics: 1-Deoxynojirimycin; Administration, Oral; Cellulose; Daucus carota; Drug Delivery Systems; Drug Discovery; Enzyme Inhibitors; Enzyme Replacement Therapy; Fabry Disease; Gaucher Disease; Humans; Lysosomal Storage Diseases; Mucolipidoses; Pyrrolidines; Rare Diseases	2016

Article

Year

N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Neurobiology of disease, 2017, Volume: 105

Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Cell Count; Cerebellum; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Gliosis; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mucolipidoses; Nerve Tissue Proteins; Psychomotor Performance; Purkinje Cells; Retina; Transient Receptor Potential Channels

2017

Overcoming the Next Barriers to Successful Therapy.

Pediatric endocrinology reviews : PER, 2016, Volume: 13 Suppl 1

Topics: 1-Deoxynojirimycin; Administration, Oral; Cellulose; Daucus carota; Drug Delivery Systems; Drug Discovery; Enzyme Inhibitors; Enzyme Replacement Therapy; Fabry Disease; Gaucher Disease; Humans; Lysosomal Storage Diseases; Mucolipidoses; Pyrrolidines; Rare Diseases

2016